111 related articles for article (PubMed ID: 23225231)
41. Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio.
Buerger K; Ernst A; Ewers M; Uspenskaya O; Omerovic M; Morgenthaler NG; Knauer K; Bergmann A; Hampel H
Biol Psychiatry; 2009 Jun; 65(11):979-84. PubMed ID: 19344890
[TBL] [Abstract][Full Text] [Related]
42. Midregional proadrenomedullin safely reduces hospitalization in a low severity cohort with infections in the ED: a randomized controlled multi-centre interventional pilot study.
Gonzalez Del Castillo J; Clemente-Callejo C; Llopis F; Irimia A; Oltra-Hostalet F; Rechner C; Schwabe A; Fernandez-Rodriguez V; Sánchez-Mora C; Giol-Amich J; Prieto-García B; Bardés-Robles I; Ortega-de Heredia MD; García-Lamberechts EJ; Navarro-Bustos C;
Eur J Intern Med; 2021 Jun; 88():104-113. PubMed ID: 33906810
[TBL] [Abstract][Full Text] [Related]
43. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.
Tzikas S; Keller T; Ojeda FM; Zeller T; Wild PS; Lubos E; Kunde J; Baldus S; Bickel C; Lackner KJ; Münzel TF; Blankenberg S
Heart; 2013 Mar; 99(6):388-95. PubMed ID: 23213173
[TBL] [Abstract][Full Text] [Related]
44. High value of mid-regional proadrenomedullin in COVID-19: A marker of widespread endothelial damage, disease severity, and mortality.
Spoto S; Agrò FE; Sambuco F; Travaglino F; Valeriani E; Fogolari M; Mangiacapra F; Costantino S; Ciccozzi M; Angeletti S
J Med Virol; 2021 May; 93(5):2820-2827. PubMed ID: 33200824
[TBL] [Abstract][Full Text] [Related]
45. Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker?
Potocki M; Ziller R; Mueller C
Curr Heart Fail Rep; 2012 Sep; 9(3):244-51. PubMed ID: 22733501
[TBL] [Abstract][Full Text] [Related]
46. Mid-regional-pro-adrenomedullin plasma levels are increased in obese adolescents.
Del Ry S; Cabiati M; Bianchi V; Caponi L; Di Cecco P; Marchi B; Randazzo E; Caselli C; Prescimone T; Clerico A; Federico G
Eur J Nutr; 2016 Apr; 55(3):1255-60. PubMed ID: 26018656
[TBL] [Abstract][Full Text] [Related]
47. Association of metabolic complications with plasma mid-regional pro-adrenomedullin level in stable kidney transplant recipients.
Suzuki Y; Katagiri F; Sato F; Fujioka T; Tanaka R; Sato Y; Mimata H; Itoh H
Clin Chim Acta; 2016 Jan; 453():160-3. PubMed ID: 26706787
[TBL] [Abstract][Full Text] [Related]
48. Development of an ultrasensitive enzyme immunoassay for human proadrenomedullin N-terminal 20 peptide and direct measurement of two molecular forms of PAMP in plasma from healthy subjects and patients with cardiovascular disease.
Hashida S; Kitamura K; Nagatomo Y; Shibata Y; Imamura T; Yamada K; Fujimoto S; Kato J; Morishita K; Eto T
Clin Biochem; 2004 Jan; 37(1):14-21. PubMed ID: 14675557
[TBL] [Abstract][Full Text] [Related]
49. Adrenomedullin: new inhibitory regulator for cortisol synthesis and secretion.
Travers S; Martinerie L; Xue QY; Perrot J; Viengchareun S; Caron KM; Blakeney ES; Boileau P; Lombès M; Pussard E
J Endocrinol; 2021 Sep; 251(1):97-109. PubMed ID: 34370692
[TBL] [Abstract][Full Text] [Related]
50. Reference intervals and longitudinal changes in copeptin and MR-proADM concentrations during pregnancy.
Joosen AMCP; van der Linden IJM; Schrauwen L; Theeuwes A; de Groot MJM; Ermens AAM
Clin Chem Lab Med; 2017 Nov; 56(1):113-119. PubMed ID: 28672769
[TBL] [Abstract][Full Text] [Related]
51. The prognostic blood biomarker proadrenomedullin for outcome prediction in patients with chronic obstructive pulmonary disease (COPD): a qualitative clinical review.
Schuetz P; Marlowe RJ; Mueller B
Clin Chem Lab Med; 2015 Mar; 53(4):521-39. PubMed ID: 25252756
[TBL] [Abstract][Full Text] [Related]
52. Levels of adrenomedullin and proadrenomedullin N-terminal 20 peptide in myocardium and aorta of spontaneously hypertensive rats and Wistar-Kyoto rats.
Qi YF; Bu DF; Shi YR; Li JX; Pang YZ; Tang CS
Sheng Li Xue Bao; 2003 Jun; 55(3):260-4. PubMed ID: 12817291
[TBL] [Abstract][Full Text] [Related]
53. Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure.
von Haehling S; Filippatos GS; Papassotiriou J; Cicoira M; Jankowska EA; Doehner W; Rozentryt P; Vassanelli C; Struck J; Banasiak W; Ponikowski P; Kremastinos D; Bergmann A; Morgenthaler NG; Anker SD
Eur J Heart Fail; 2010 May; 12(5):484-91. PubMed ID: 20215339
[TBL] [Abstract][Full Text] [Related]
54. Activity of the adrenomedullin system to personalise post-discharge diuretic treatment in acute heart failure.
Kozhuharov N; Ng L; Wussler D; Strebel I; Sabti Z; Hartmann O; Eltayeb M; Squire I; Nowak A; Rieger M; Martin J; Michou E; Stefanelli S; Puelacher C; Shrestha S; Belkin M; Zimmermann T; Lopez-Ayala P; Struck J; Bergmann A; Mebazaa A; Blet A; Gualandro DM; Breidthardt T; Mueller C
Clin Res Cardiol; 2022 Jun; 111(6):627-637. PubMed ID: 34302189
[TBL] [Abstract][Full Text] [Related]
55. Assessment of the Stability of Midregional Proadrenomedullin in Different Biological Matrices.
Angeletti S; Legramante JM; Lia MS; D'Amico L; Fogolari M; Cella E; De Cesaris M; De Angelis F; Pieri M; Terrinoni A; Bernardini S; Minieri M
Lab Med; 2023 Jan; 54(1):41-46. PubMed ID: 35713618
[TBL] [Abstract][Full Text] [Related]
56. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528
[TBL] [Abstract][Full Text] [Related]
57. Adrenomedullin and arterial stiffness: integrative approach combining monocyte ADM expression, plasma MR-Pro-ADM, and genome-wide association study.
Beygui F; Wild PS; Zeller T; Germain M; Castagné R; Lackner KJ; Münzel T; Montalescot G; Mitchell GF; Verwoert GC; Tarasov KV; Trégouët DA; Cambien F; Blankenberg S; Tiret L
Circ Cardiovasc Genet; 2014 Oct; 7(5):634-41. PubMed ID: 25053723
[TBL] [Abstract][Full Text] [Related]
58. [Predictive value of baseline plasma midregional fragment of pro-adrenomedullin level on long-term outcome of postural tachycardia syndrome children treated with midodrine hydrochloride].
Li H; Zhang F; Wang Y; Liu P; Zhang C; Feng X; Du J; Jin H
Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Jun; 43(6):507-10. PubMed ID: 26420118
[TBL] [Abstract][Full Text] [Related]
59. Gene transcription and synthesis of adrenomedullin by cultured human renal cells.
Lai KN; Leung JC; Yeung VT; Lewis LK; Nicholls MG
Biochem Biophys Res Commun; 1998 Mar; 244(2):567-72. PubMed ID: 9514865
[TBL] [Abstract][Full Text] [Related]
60. Changes of plasma adrenomedullin and proadrenomedullin N-terminal 20 peptide concentrations in patients with heart failure.
Gao YQ; Li ZL; Wu HC; Tang CS; Zhong P; Lu Q; Yan QN
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):632-4. PubMed ID: 12376296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
